Contraception and reproductive planning during the COVID-19 pandemic.

Abstract

INTRODUCTION:

The coronavirus disease (COVID-19) is a global health emergency. Major disruption to healthcare services during the current COVID-19 pandemic will last even after its peak. Sexual and reproductive health (SRH), specially contraception, needs to be understood as an essential service.

AREAS COVERED:

This paper is a narrative review. Data from PubMed/MEDLINE, Scopus, and websites of scientific societies were screened during the months of April and May 2020. It addresses the main aspects related to contraception during the COVID-19 pandemic, with special emphasis on family planning services, extended use of long-acting reversible contraceptive (LARC) methods, drug interactions, and thromboembolism risk. We also specified some issues focused on the Brazilian reality.

EXPERT OPINION:

Ensuring proper contraception use in the COVID-19 time is very important. We encourage women, healthcare providers, policymakers, and the society to consider SRH services as priority.

• Authors: Edson Santos Ferreira-Filho, Nilson Roberto de Melo, Isabel Cristina Esposito Sorpreso, Luis Bahamondes, Ricardo Dos Santos Simões, José Maria Soares-Júnior, Edmund Chada Baracat
• Journal: Expert review of clinical pharmacology (Expert Rev Clin Pharmacol) Vol. 13 Issue 6 Pg. 615-622 (Jun 2020) ISSN: 1751-2441 [Electronic] England
• PMID: 32538185 (Publication Type: Journal Article, Review)

Topics

• Adult
• Betacoronavirus
• COVID-19
• Contraception
• Coronavirus Infections (drug therapy, epidemiology)
• Drug Interactions
• Family Planning Services
• Female
• Humans
• Pandemics
• Pneumonia, Viral (drug therapy, epidemiology)
• Reproductive Health
• SARS-CoV-2
• Sexual Health
• Venous Thromboembolism (etiology)